NOVO NORDISK
Updated 260 days ago
Hypersensitivity: Serious hypersensitivity reactions (eg, anaphylaxis, angioedema) have been reported in patients treated with OzempicĀ®. If hypersensitivity reactions occur, discontinue use of OzempicĀ®; treat promptly per standard of care, and monitor until signs and symptoms resolve. Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist...
Learn how to start your patients with type 2 diabetes on OzempicĀ® (semaglutide) injection virtually or in person and access downloadable resources. Read Important Safety and Prescribing Information, including Boxed Warning.